Drug to Treat Skin Cancer in Sight

Friday, November 27, 2015

Skin Cancer Drug

A study published in the journal ‘Cancer Research’ reveals that scientists from Sanford Burnham Prebys Medical Discovery Institute have discovered a new drug that could possibly treat deadly forms of skin cancer such as melanoma and would prevent its resurgence.

The new drug named SBI–756 targets a specific molecular machine known as the translation initiation complex that plays a critical role in a translating messenger RNA (mRNA) into proteins. In cancer cells, the translation initiation complex is impaired, which leads to extra protein production. This aids in tumour growth. SBI–756 causes the translation complex to dissociate, suppressing the melanoma cell growth.

At present, about 50% of the melanomas are caused by mutations in a specific gene called BRAF. Patients with this condition are generally prescribed vemurafenib that inhibits BRAF and shrinks tumours. However, the tumours may resurface after weeks, months or years. Researchers found out that if vemurafenib is administered with SBI–756, then the tumours would disappear and never return, resurface or form.

The most wonderful and precious element of universe is the human life which can only be guided by the right knowledge and right attitude. So, here is an ocean of knowledge, both in English and Hindi encompassing every detail and each facet of human life which ‘one must know’ in order to grow and attain the summits of success. A team of around 200 dedicated members is working ceaselessly to turn such a colossal dream into reality. We are confident that this portal will help bring change in people across the world.

Content creation, research, development and execution done in-house at Aatman Innovations.